A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Recent news on Gadodiamide


FDA Requests Boxed Warning for Contrast Agents Used to Improve MRI  -  25 May 2007
NewsBlaze,Five gadolinium-based contrast agents have been approved for use in the United States: Magnevist (gadopentetate dimeglumine), Ominiscan (gadodiamide);

Former Nurse GE for Disease Caused By Omniscan  -  May 11, 2007
HULIQ,Much has been made public recently about the relationship between gadodiamide contrast agents and NSF. In its Public Health Advisory last December,

Link between MRI contrast agent and nephrogenic systemic fibrosis  -  Jan 28, 2007
News-Medical.net,..."At this point, the data clearly show the vast majority of NSF cases are associated with the use of gadodiamide." NSF, an emerging systemic disorder

APS: Contrast Media Used in MRI and Nephrogenic Systemic .........  -  Feb 9, 2007
ANP Pers Support,In the large majority of cases, the product used for MRI was gadodiamide. gadoversetamide (4,5,8) (OPTIMARK(R)) were used. The physiopathology of this

MRI Contrast Agent Linked To Complication In Renal Patients  -  Feb 8, 2007
Medical News Today (press release),..."Despite the paucity of definitive data, the association is so strong, that both the FDA and the company that makes gadodiamide have sent out warnings about

Contrast Media Used in MRI and Nephrogenic Systemic Fibrosis in ...  -  Feb 9, 2007
netPR.pl (komunikaty prasowe),In the large majority of cases, the product used for MRI was gadodiamide (OMNISCAN(R)), in a smaller number of cases gadopentetate dimeglumine

Contrast Media Used in MRI and Nephrogenic Systemic Fibrosis in ...  -  Feb 9, 2007
Earthtimes.orgIn the large majority of cases, the productused for MRI was gadodiamide (OMNISCAN(R)), in a smaller number of casesgadopentetate dimeglumine (MAGNEVIST(R))

MRI Contrast Agents May Pose Risk for Patients With Kidney Disease  -  Jan 16, 2007
Journal of American Medical Association (subscription),The agency noted that in a study of patients with severe renal disease, 13 of 370 who were administered a gadolinium-based contrast agent called gadodiamide

Irreversible Myocardial Injury: Assessment with Cardiovascular ...  -  Jan 9, 2007
HeartZine,...infarction were imaged with the same sequence by the same operator at 1.5 and 3.0 T. After cine imaging, a bolus of gadodiamide was administered.

Effectiveness of Management Strategies for Renal Artery Stenosis ...  -  Dec 18, 2006
Annals of Internal MedicineSafety of CO(2)- and gadodiamide-enhanced angiography for the evaluation and percutaneous treatment of renal artery stenosis in patients with chronic renal

Systematic Review: Comparative Effectiveness of Management ...  Oct 24, 2006
Safety of CO(2)- and gadodiamide-enhanced angiography for the evaluation and percutaneous treatment of renal artery stenosis in patients with chronic renal ... -Annals of Internal Medicine

Single-Shot Inversion Recovery TrueFISP for Assessment of ...  Mar 9, 2006
Forty-three patients with myocardial infarction were examined on a 1.5-T MR system 10 min after administration of contrast material (gadodiamide, 0.2 mmol/kg ... - Am J Roentgenology (subscription)


This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional